Stockscreener 앱 받기
20.47
3.12%
0.62
시간 외 거래:
20.47
전일 마감가:
$19.85
열려 있는:
$19.99
하루 거래량:
813.49K
Relative Volume:
0.74
시가총액:
$947.03M
수익:
$82.71M
순이익/손실:
$-102.24M
주가수익비율:
-5.5777
EPS:
-3.67
순현금흐름:
$-76.57M
1주 성능:
+7.91%
1개월 성능:
+2.61%
6개월 성능:
+75.86%
1년 성능:
+66.97%
1일 변동 폭
$19.73
$20.72
1주일 범위
$19.00
$21.00
52주 변동 폭
$3.42
$21.71
Urogen Pharma Ltd Stock (URGN) Company Profile
명칭
Urogen Pharma Ltd
전화
972 9 770 7601
주소
9 HA'TA'ASIYA ST, RA'ANANA
URGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
20.47 | 918.34M | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-06-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-19 | 재개 | Ladenburg Thalmann | Buy |
| 2024-08-22 | 개시 | Guggenheim | Buy |
| 2023-02-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-27 | 개시 | Berenberg | Buy |
| 2020-04-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-13 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-09 | 개시 | National Securities | Neutral |
| 2019-05-30 | 개시 | JP Morgan | Neutral |
| 2019-05-29 | 개시 | Goldman | Neutral |
| 2019-01-29 | 개시 | H.C. Wainwright | Buy |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-04-04 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | 개시 | Ladenburg Thalmann | Buy |
| 2017-11-15 | 재확인 | Oppenheimer | Outperform |
| 2017-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Urogen Pharma Ltd 주식(URGN)의 최신 뉴스
Automated trading signals detected on UroGen Pharma Ltd.2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Can UroGen Pharma Ltd. stock withstand economic slowdownCPI Data & Weekly Setup with High ROI Potential - newser.com
Using data tools to time your UroGen Pharma Ltd. exitTrade Ideas & Free Safe Entry Trade Signal Reports - newser.com
Does UroGen Pharma Ltd. show high probability of rebound2025 Key Highlights & Capital Protection Trading Alerts - newser.com
UroGen: Expect Rough Patch Before Strong Recovery In 2026 (NASDAQ:URGN) - Seeking Alpha
Is UroGen Pharma Ltd. stock bottoming outPortfolio Growth Summary & Community Verified Trade Signals - newser.com
How UroGen Pharma Ltd. stock reacts to job market dataJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Applying Elliott Wave Theory to UroGen Pharma Ltd.2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Can UroGen Pharma Ltd. stock resist sector downturnsJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Is UroGen Pharma Ltd. (UR8) stock undervalued after correctionMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
How UroGen Pharma Ltd. stock compares to industry benchmarks2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
What indicators show strength in UroGen Pharma Ltd.Gold Moves & Safe Capital Allocation Plans - newser.com
Why UroGen Pharma Ltd. (UR8) stock stays on buy listsWeekly Profit Report & Community Trade Idea Sharing - newser.com
How UroGen Pharma Ltd. (UR8) stock behaves in tightening cyclesJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
What analysts say about UroGen Pharma Ltd stockPrice Volatility Patterns & High Return Stock Ideas - earlytimes.in
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025 - The Manila Times
Migdal Insurance & Financial Holdings Ltd. Reduces Position in Urogen Pharma $URGN - MarketBeat
Published on: 2025-10-30 00:50:10 - newser.com
UroGen Pharma Hits Day High with 9.46% Surge in Stock Price - Markets Mojo
Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Urogen Pharma (URGN) to Release Earnings on Wednesday - MarketBeat
Allianz Asset Management GmbH Invests $203,000 in Urogen Pharma $URGN - MarketBeat
Urogen Pharma (NASDAQ:URGN) Trading 10.1% HigherHere's What Happened - MarketBeat
Is UroGen Pharma Ltd. stock attractive for ETFs2025 Market WrapUp & Stock Market Timing Techniques - fcp.pa.gov.br
HC Wainwright Reaffirms Buy Rating for Urogen Pharma (NASDAQ:URGN) - MarketBeat
Urogen Pharma Ltd (URGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):